162 related articles for article (PubMed ID: 31084445)
1. Design of selegiline-loaded bio-nanosuspension for the management of depression using novel bio-retardant from
Tyagi Y; Madhav NVS
Drug Dev Ind Pharm; 2019 Aug; 45(8):1351-1360. PubMed ID: 31084445
[No Abstract] [Full Text] [Related]
2. Inbuilt novel bioretardant feature of biopolymer isolated from
Tyagi Y; Madhav NS
J Drug Assess; 2020; 9(1):72-81. PubMed ID: 32341840
[No Abstract] [Full Text] [Related]
3. Development of an amorphous nanosuspension by sonoprecipitation-formulation and process optimization using design of experiment methodology.
Gajera BY; Shah DA; Dave RH
Int J Pharm; 2019 Mar; 559():348-359. PubMed ID: 30721724
[TBL] [Abstract][Full Text] [Related]
4. Nanocrystal-based drug delivery system of risperidone: lyophilization and characterization.
Gol D; Thakkar S; Misra M
Drug Dev Ind Pharm; 2018 Sep; 44(9):1458-1466. PubMed ID: 29619857
[TBL] [Abstract][Full Text] [Related]
5. Biopharmaceutical Potential of Selegiline Loaded Chitosan Nanoparticles in the Management of Parkinson's Disease.
Rukmangathen R; Yallamalli IM; Yalavarthi PR
Curr Drug Discov Technol; 2019; 16(4):417-425. PubMed ID: 29669501
[TBL] [Abstract][Full Text] [Related]
6. Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of loratadine: Preparation, characterization, and in vivo evaluation.
Alshweiat A; Csóka I; Tömösi F; Janáky T; Kovács A; Gáspár R; Sztojkov-Ivanov A; Ducza E; Márki Á; Szabó-Révész P; Ambrus R
Int J Pharm; 2020 Apr; 579():119166. PubMed ID: 32084574
[TBL] [Abstract][Full Text] [Related]
7. Formulation and evaluation of mucoadhesive buccal films impregnated with carvedilol nanosuspension: a potential approach for delivery of drugs having high first-pass metabolism.
Rana P; Murthy RS
Drug Deliv; 2013; 20(5):224-35. PubMed ID: 23651066
[TBL] [Abstract][Full Text] [Related]
8. Design and Evaluation of Eudragit RS-100 Based Itraconazole Nanosuspension for Ophthalmic Application.
Pawar P; Duduskar A; Waydande S
Curr Drug Res Rev; 2021; 13(1):36-48. PubMed ID: 32990554
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Solubility and Dissolution Rate of Lacidipine Nanosuspension: Formulation Via Antisolvent Sonoprecipitation Technique and Optimization Using Box-Behnken Design.
Kassem MAA; ElMeshad AN; Fares AR
AAPS PharmSciTech; 2017 May; 18(4):983-996. PubMed ID: 27506564
[TBL] [Abstract][Full Text] [Related]
10. A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes.
Patel PJ; Gajera BY; Dave RH
Drug Dev Ind Pharm; 2018 Dec; 44(12):1942-1952. PubMed ID: 30027778
[TBL] [Abstract][Full Text] [Related]
11. Eudragit-based nanosuspension of poorly water-soluble drug: formulation and in vitro-in vivo evaluation.
Yadav SK; Mishra S; Mishra B
AAPS PharmSciTech; 2012 Dec; 13(4):1031-44. PubMed ID: 22893314
[TBL] [Abstract][Full Text] [Related]
12. Enhanced Dermal Delivery of Flurbiprofen Nanosuspension Based Gel: Development and Ex Vivo Permeation, Pharmacokinetic Evaluations.
Oktay AN; Ilbasmis-Tamer S; Uludag O; Celebi N
Pharm Res; 2021 Jun; 38(6):991-1009. PubMed ID: 34086139
[TBL] [Abstract][Full Text] [Related]
13. Formulation and Evaluation of Isradipine Nanosuspension and Exploring its Role as a Potential Anticancer Drug by Computational Approach.
Mohapatra PK; Srivastava R; Varshney KK; Babu SH
Anticancer Agents Med Chem; 2022; 22(10):1984-2001. PubMed ID: 34353274
[TBL] [Abstract][Full Text] [Related]
14. Preparation of ritonavir nanosuspensions by microfluidization using polymeric stabilizers: I. A Design of Experiment approach.
Karakucuk A; Celebi N; Teksin ZS
Eur J Pharm Sci; 2016 Dec; 95():111-121. PubMed ID: 27181836
[TBL] [Abstract][Full Text] [Related]
15. Formulation and comparative evaluation of HPMC and water soluble chitosan-based sparfloxacin nanosuspension for ophthalmic delivery.
Ambhore NP; Dandagi PM; Gadad AP
Drug Deliv Transl Res; 2016 Feb; 6(1):48-56. PubMed ID: 26545605
[TBL] [Abstract][Full Text] [Related]
16. Nanosuspension improves tretinoin photostability and delivery to the skin.
Lai F; Pireddu R; Corrias F; Fadda AM; Valenti D; Pini E; Sinico C
Int J Pharm; 2013 Dec; 458(1):104-9. PubMed ID: 24135683
[TBL] [Abstract][Full Text] [Related]
17. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
Sawant KK; Patel MH; Patel K
Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a novel, co-processed bio-based polymer, and its effect on mucoadhesive strength.
Singh S; Nwabor OF; Ontong JC; Kaewnopparat N; Voravuthikunchai SP
Int J Biol Macromol; 2020 Feb; 145():865-875. PubMed ID: 31783076
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of stavudine loaded injectable polymeric particulate systems.
Srivastava S; Sinha VR
Curr Drug Deliv; 2011 Jul; 8(4):436-47. PubMed ID: 21235469
[TBL] [Abstract][Full Text] [Related]
20. Design, development and characterization of ketorolac tromethamine polymeric nanosuspension.
Jadhav PA; Yadav AV
Ther Deliv; 2019 Sep; 10(9):585-597. PubMed ID: 31581882
[No Abstract] [Full Text] [Related]
[Next] [New Search]
